is an acquired cutaneous depigmentation disorder which has a deleterious effect on the psychosexual function of many individuals; the genitalia are the common site for depigmentation. Here, the authors report two cases of focal vitiligo affecting the scrotum of the genital organs which were successfully treated by autologous cultured melanocyte transplantation.
INTRODUCTION
Vitiligo is an acquired cutaneous depigmentation disorder, which has a deleterious effect on the psychosexual function of many individuals; the genitalia are the common site for depigmentation [1] . There are few reports about treatment of genital vitiligo [2] [3] [4] [5] . Only one report discovered by the authors refers to depigmentation of the scrotum [5] . The importance of follicles as a reservoir of melanocytes is emphasized by the well-known fact that glabrous skin (i.e., non-hair-bearing skin), such as genitalia, rarely responds to therapy unless it has some residual pigment [6] . Therefore, the treatment of genital vitiligo is difficult. Here, the authors report two cases of focal vitiligo affecting the scrotum of the genital organs which were successfully treated by autologous cultured melanocyte transplantation.
METHODS
Donor skin was obtained from the patients' normally pigmented area of the abdomen or Electronic supplementary material The online version of this article (doi:10.1007/s13555-014-0050-5) contains supplementary material, which is available to authorized users. thighs. Specimens were washed with calciumfree Hanks' solution, incubated in 0.25% trypsin solution for 10 min, followed by incubation with 0.02% ethylenediaminetetraacetic acid (EDTA) solution for 10 min at 37°C. Cells were separated from the epidermal sheet under a stereomicroscope. The cell suspension was centrifuged, re-suspended with Hu16 medium (F12 medium with 20 ng/ml basic fibroblast growth factor, 20 lg/ml 3-isobutyl-1methylxanthine, 10 ng/ml cholera toxin, 50 lg/ ml gentamicin, and 10% fetal bovine serum) and seeded into a culture flask. Cells were incubated in a humidified 5% CO 2 atmosphere at 37°C.
Geneticin (Sigma-Aldrich, Saint Louis, MO, USA) was added to the medium (100 lg/ml) 3 days later to eliminate contaminating cells. After primary cultures became confluent, the melanocytes were detached by 0.125% trypsin/ 0.01% EDTA solution, centrifuged, resuspended, diluted at a ratio of 1:2-1:3, and seeded into culture flasks for subculture. After the cell number met the requirement for transplantation (approximately 80,000 melanocytes/cm 2 ), the melanocytes were detached as described above, centrifuged, resuspended in F12 medium, and transferred to the operating room for transplantation in a timely manner.
A topical anesthetic, lidocaine cream, was applied 2-4 h before transplantation. The recipient areas were cleaned with 70% alcohol and treated with UltraPulse Ò CO 2 laser (Lumenis, Santa Clara, CA, USA; pulse rate 30-50 Hz at an energy level of 225 mJ per pulse) to remove the epidermis. The melanocyte suspension was applied to the laser-denuded area with a pipette at a density of 80,000 melanocytes/cm 2 . The recipient site was immediately covered with silicone gauze, followed by a gauze-soaked in F12 culture medium, and, finally, secured with Tegaderm Eighteen months post-transplantation, the vitiliginous area of the scrotum was almost completely repigmented (Fig. 1) . The depigmented lesion had not received phototherapy before or after transplantation, and the patient was very satisfied with the cosmetic results. 
DISCUSSION
The genital is a commonly affected site for vitiligo in men, and it is sometimes the only site affected [7] . The treatment of genital vitiligo is quite complex. There are very few reports in the literature for the treatment of genital vitiligo.
Souza Leite et al. [4] reported one case of genital vitiligo successfully treated by pimecrolimus. However, this patient had a short duration of the disease considering the existence of residual melanocytes. Therefore, the use of medication was considered to be a better option. For vitiligo with longer duration or vitiligo without residual pigment in genitals, surgical intervention is recommended. Mulekar et al. [3] reported three cases of focal vitiligo affecting the glans and shaft of the penis successfully treated by antilogous non-cultured melanocytekeratinocyte cell transplantation. Differing from their cases, the current transplantation site is located on the scrotum, and the scheme used was autologous cultured melanocyte transplantation. Mulekar et al. [3] needed to perform two rounds of surgery to achieve satisfying repigmentation, whereas the current authors achieved 90% repigmentation in case 1. Redondo et al. [5] used a graft of autologous melanocytes cultured on a denuded amniotic membrane to treat a patient with a scrotal lesion and achieved good regimentation. However, the current study did not use a denuded amniotic membrane, and achieved the same effect. 
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